Canada markets closed

PharmaCielo Ltd. (PCLO.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
1.8000-0.0700 (-3.74%)
At close: 4:00PM EST
Currency in CAD

Valuation Measures

Market Cap (intraday) 5248.88M
Enterprise Value 3257.52M
Trailing P/E N/A
Forward P/E 14.86
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)102.43
Price/Book (mrq)5.73
Enterprise Value/Revenue 3105.99
Enterprise Value/EBITDA 6-8.08

Trading Information

Stock Price History

Beta (5Y Monthly) 3.73
52-Week Change 3-47.83%
S&P500 52-Week Change 318.43%
52 Week High 33.5700
52 Week Low 30.4100
50-Day Moving Average 31.8485
200-Day Moving Average 30.9433

Share Statistics

Avg Vol (3 month) 3397.94k
Avg Vol (10 day) 3229.95k
Shares Outstanding 5138.27M
Float 119.41M
% Held by Insiders 12.31%
% Held by Institutions 10.01%
Shares Short (Jan. 14, 2021) 4572.93k
Short Ratio (Jan. 14, 2021) 41.47
Short % of Float (Jan. 14, 2021) 4N/A
Short % of Shares Outstanding (Jan. 14, 2021) 40.41%
Shares Short (prior month Dec. 14, 2020) 4631.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:11
Last Split Date 3Jan. 17, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-1,365.74%

Management Effectiveness

Return on Assets (ttm)-42.05%
Return on Equity (ttm)-76.26%

Income Statement

Revenue (ttm)2.43M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-80.10%
Gross Profit (ttm)643.48k
EBITDA -31.86M
Net Income Avi to Common (ttm)-32.57M
Diluted EPS (ttm)-0.3100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.33M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)1.41M
Total Debt/Equity (mrq)3.78
Current Ratio (mrq)2.81
Book Value Per Share (mrq)0.31

Cash Flow Statement

Operating Cash Flow (ttm)-21.52M
Levered Free Cash Flow (ttm)-18.44M